N@N

Verily's plan for 2025: Raise money, pivot to AI, and break up with Google

Verily, a life sciences company under Alphabet, is reportedly seeking to raise $1 billion in funding to support its expansion into AI-driven drug discovery and development, as well as to potentially separate from Google. This move comes as part of a broader strategy to leverage AI in healthcare, aiming to enhance drug discovery processes, diagnostics, and patient care. The fundraising effort, which could value Verily at $10 billion, reflects a significant pivot towards becoming an independent entity, distancing itself from Google's overarching influence. This strategic shift is also seen as a response to the competitive landscape in AI and healthcare, where companies like Verily need substantial capital to innovate and stay ahead. The separation from Google is expected to provide Verily with more autonomy in decision-making, potentially attracting investors looking for pure-play health tech investments.

Read the Full Business Insider Article at:
[ https://www.businessinsider.com/verily-fundraise-2025-ai-strategy-google-breakup-2024-12 ]